Wingderm®'s Lasermach Achieves FDA Clearance for All Wavelengths
Wingderm®, a leading manufacturer in medical aesthetic devices, has made significant strides by recently announcing that its Lasermach system has acquired expanded clearance from the U.S. Food and Drug Administration (FDA). This latest milestone allows Lasermach to operate effectively across all three wavelengths: 755 nm, 808 nm, and 1064 nm.
With this expanded clearance, Wingderm® has reaffirmed its commitment to providing versatile solutions for hair removal, as well as treatments for various benign vascular lesions. The system now features a Mixed Wavelength Handpiece that combines all three wavelengths to enhance temporary hair reduction and tackle vascular-dependent lesions effectively. Furthermore, the addition of Single Wavelength Handpieces allows for focused treatment using any of the three wavelengths, enabling permanent hair reduction for all skin types, ranging from Fitzpatrick skin types I to VI.
The enhanced capabilities of the Lasermach system represent a major upgrade from its previous single-wavelength configuration. The device's expanded versatility empowers medical spas and aesthetic professionals to address a broader range of hair removal needs with a single platform. By simplifying device selection and optimizing daily operations, clinics can enhance patient satisfaction and operational efficiency.
This impressive system will be showcased at the upcoming American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 27–29 in Denver, Colorado. Dermatology professionals and industry partners are encouraged to visit Booth 4342 to learn more about the Lasermach system, exchange insights, and discover how it can fit into their practices.
Since its inception in 2016, Wingderm® has strived to redefine the landscape of medical aesthetics through innovation. With a mission encapsulated in the phrase "Aesthetics Technology, Easy to Achieve," Wingderm® has successfully installed over 30,000 units across more than 80 countries. The company's products have gained recognition for their safety and effectiveness, earning the trust of both experts and beauty enthusiasts worldwide.
Wingderm® remains steadfast in its pursuit of excellence, ensuring that healthcare providers have access to reliable, intelligent photoelectric medical aesthetic devices. As the demand for effective hair removal solutions continues to grow, Lasermach stands out as a testament to Wingderm's dedication to advancing industry standards.
For more detailed information about the Lasermach system and Wingderm®'s offerings, visit their official website at https://www.wingderm.com.
As more professionals seek to enhance their service offerings, the FDA clearance for Lasermach is expected to lead to exciting developments in aesthetic medicine, providing practitioners with the tools they need to keep their clients satisfied and happy. The future looks bright for aesthetic clinics powered by Wingderm®'s innovations.
With this expanded clearance, Wingderm® has reaffirmed its commitment to providing versatile solutions for hair removal, as well as treatments for various benign vascular lesions. The system now features a Mixed Wavelength Handpiece that combines all three wavelengths to enhance temporary hair reduction and tackle vascular-dependent lesions effectively. Furthermore, the addition of Single Wavelength Handpieces allows for focused treatment using any of the three wavelengths, enabling permanent hair reduction for all skin types, ranging from Fitzpatrick skin types I to VI.
The enhanced capabilities of the Lasermach system represent a major upgrade from its previous single-wavelength configuration. The device's expanded versatility empowers medical spas and aesthetic professionals to address a broader range of hair removal needs with a single platform. By simplifying device selection and optimizing daily operations, clinics can enhance patient satisfaction and operational efficiency.
This impressive system will be showcased at the upcoming American Academy of Dermatology (AAD) Annual Meeting, scheduled for March 27–29 in Denver, Colorado. Dermatology professionals and industry partners are encouraged to visit Booth 4342 to learn more about the Lasermach system, exchange insights, and discover how it can fit into their practices.
Since its inception in 2016, Wingderm® has strived to redefine the landscape of medical aesthetics through innovation. With a mission encapsulated in the phrase "Aesthetics Technology, Easy to Achieve," Wingderm® has successfully installed over 30,000 units across more than 80 countries. The company's products have gained recognition for their safety and effectiveness, earning the trust of both experts and beauty enthusiasts worldwide.
Wingderm® remains steadfast in its pursuit of excellence, ensuring that healthcare providers have access to reliable, intelligent photoelectric medical aesthetic devices. As the demand for effective hair removal solutions continues to grow, Lasermach stands out as a testament to Wingderm's dedication to advancing industry standards.
For more detailed information about the Lasermach system and Wingderm®'s offerings, visit their official website at https://www.wingderm.com.
As more professionals seek to enhance their service offerings, the FDA clearance for Lasermach is expected to lead to exciting developments in aesthetic medicine, providing practitioners with the tools they need to keep their clients satisfied and happy. The future looks bright for aesthetic clinics powered by Wingderm®'s innovations.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.